A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity



van der Lee, Sven J ORCID: 0000-0003-1606-8643, Conway, Olivia J, Jansen, Iris, Carrasquillo, Minerva M, Kleineidam, Luca, van den Akker, Erik, Hernández, Isabel, van Eijk, Kristel R, Stringa, Najada, Chen, Jason A
et al (show 91 more authors) (2019) A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. Acta Neuropathologica, 138 (2). 237 - 250.

[img] Text
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.pdf - Published Version

Download (1MB) | Preview
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 18 Nov 2019 09:46
Last Modified: 29 Sep 2020 07:25
DOI: 10.1007/s00401-019-02026-8
URI: http://livrepository.liverpool.ac.uk/id/eprint/3061906